US recalls two million needles for infusion sets
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The US Food and Drug Administration has recalled more than two million needles made by a Japanese firm over fears they can introduce silicone fragments in patients' bodies.
The FDA said in a statement Tuesday that Nipro Medical Corp. had taken back products made between January 2007 and August 2009 after inspections in October last year showed between 60 and 72 percent of the needles were defective.
The needles are used to access ports implanted under the skin of chronically ill patients so that blood can be withdrawn or medications infused repeatedly.
Testing showed that when the needles were inserted into the port they sometimes produced slivers or "cores" of silicone, which could be flushed into the patient's body with adverse results.
Although 20 manufacturers produce the needles, only those made by Nipro were found to frequently result in coring.
"We will continue to work with manufacturers to address coring issues as quickly and thoroughly as possible," said Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health.
jm/ach
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments